CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
76.51
-1.74 (-2.22%)
Sep 22, 2026, 12:48 PM EDT - Market open
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $6.78 billion as of September 22, 2026. Its market cap has increased by 141.04% in one year.
Market Cap
6.78B
Enterprise Value
5.76B
1-Year Change
141.04%
Ranking
Category
Stock Price
$76.51
ChartMarket Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $6.78B, an increase of 462.27%. That is a compound annual growth rate of 91.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 6.78B | 102.49% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 7.96B |
| Immunovant | 7.63B |
| Ionis Pharmaceuticals | 7.39B |
| Belite Bio | 6.88B |
| Rhythm Pharmaceuticals | 6.73B |
| Oruka Therapeutics | 6.29B |
| Mirum Pharmaceuticals | 5.96B |
| Travere Therapeutics | 5.92B |